Search Within

Mark Blaine Geyer

Formats
  1. Meeting Abstract (43)
  2. Journal Article (37)
  3. Review (4)
  4. Research Letter (3)
  5. Book Section (2)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Adult Leukemia (91)
  2. Center for Hematologic Malignancies (91)
  3. Department of Medicine (91)
  4. Hematologic Malignancies, Division of (91)
  5. Weinberg Fellows (91)
  6. Epidemiology and Biostatistics (34)

More Groups

People
  1. Jae Park (48)
  2. Martin Tallman (23)
  3. Aaron Goldberg (16)
  4. Andriy Derkach (16)
  5. Lindsey Roeker (15)
  6. Mikhail Roshal (15)

More People

Years
  1. 2025 (4)
  2. 2024 (12)
  3. 2023 (14)
  4. 2022 (6)
  5. 2021 (8)
  6. 2020 (10)

More Years

Publications
  1. Blood (36)
  2. Leukemia and Lymphoma (8)
  3. Blood Advances (5)
  4. Haematologica (3)
  5. Journal of Clinical Oncology (3)
  6. Cytotherapy (2)

More Publications

Publishers
  1. American Society of Hematology (41)
  2. Taylor & Francis Group (9)
  3. Elsevier Inc. (7)
  4. American Society of Clinical Oncology (4)
  5. Nature Publishing Group (4)
  6. American Association for Cancer Research (3)

More Publishers

Results (91)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BRAF in the cross-hairs
    Review

    Geyer, M. B.; Abdel-Wahab, O.; Tallman, M. S.
    Expert Review of Hematology (2019)

    Fulltext@MSK | Save
  • First CAR to pass the road test: Tisagenlecleucel's drive to FDA approval
    Journal Article

    Geyer, M. B.
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Resource utilization early after chimeric antigen receptor (CAR) T cell infusion for hematologic malignancies
    Meeting Abstract

    Shah, G. L.; Park, J. H.; Sauter, C. S.; Duck, E.; Halton, E.; Palomba, M. L.; Batlevi, C. L.; Younes, A.; Geyer, M. B.; Smith, E. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Blinatumomab administered concurrently with oral tyrosine kinase inhibitor therapy is a well-tolerated consolidation strategy and eradicates measurable residual disease in adults with Philadelphia chromosome positive acute lymphoblastic leukemia
    Meeting Abstract

    King, A. C.; Pappacena, J.; Tallman, M. S.; Park, J. H.; Geyer, M. B.
    Blood (2018)

    Fulltext@MSK | Save
  • Hypofibrinogenemia and disseminated intravascular coagulation rarely complicate treatment-naive acute lymphoblastic leukemia
    Meeting Abstract

    Gaulin, C.; Chan, A.; Geyer, M. B.; Park, J. H.; Mantha, S.; Tallman, M. S.
    Blood (2018)

    Fulltext@MSK | Save
  • Ruxolitinib in combination with dasatinib and dexamethasone is an active and well-tolerated chemotherapy-sparing oral induction regimen for adults with Philadelphia chromosome-positive ALL: Results of a phase I trial
    Meeting Abstract

    Geyer, M. B.; Burke, P. W.; King, A. C.; Mauro, M. J.; Tallman, M. S.; Levine, R. L.; Sherr, C. J.; Douer, D.; Park, J. H.
    Blood (2018)

    Fulltext@MSK | Save
  • Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of MRD negativity in adults ages 18-60 with Philadelphia chromosome-negative acute lymphoblastic leukemia and lymphoblastic lymphoma
    Meeting Abstract

    Geyer, M. B.; Ritchie, E. K.; Rao, A. V.; Cazacu, M. I.; Vemuri, S.; Tallman, M. S.; Douer, D.; Park, J. H.
    Blood (2018)

    Fulltext@MSK | Save
  • Autologous CD19-Targeted CAR T cells in patients with residual CLL following initial purine analog-based therapy
    Journal Article

    Geyer, M. B.; Rivière, I.; Sénéchal, B.; Wang, X.; Wang, Y.; Purdon, T. J.; Hsu, M.; Devlin, S. M.; Halton, E.; Lamanna, N.; more...
    Molecular Therapy (2018)

    Fulltext@MSK | Save
  • Concurrent therapy of chronic lymphocytic leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia utilizing CD19-targeted CAR T-cells
    Journal Article

    Geyer, M. B.; Manjunath, S. H.; Evans, A. G.; Park, J. H.; Davila, M. L.; Cutler, C. S.; Wang, X.; Wang, Y.; Senechal, B.; Rivière, I.; more...
    Leukemia and Lymphoma (2018)

    Fulltext@MSK | Save